https://www.selleckchem.com/pr....oducts/poziotinib-hm
Systemic AHR was also lower in never-smokers with COPD. Thus, AHR expression protects against the development of COPD by controlling interrelated mechanisms involved in the pathogenesis of this disease. This study identifies the AHR as a new, central player in the homeostatic maintenance of lung health, providing a foundation for the AHR as a novel therapeutic target and/or predictive biomarker in chronic lung disease. What is the central question of this study? What is the protective benefit of n-3 polyunsaturated fatty ac
Like
Comment
Share
